AmorChem, Université Laval and CHU de Québec collaborate on the development of a treatment for Friedreich’s Ataxia
NEWS RELEASE AmorChem, Université Laval and CHU de Québec collaborate on the development of a treatment for Friedreich’s Ataxia Montreal, August 4, 2014 – AmorChem, Université Laval and the CHU de Québec are happy to announce the start of a collaboration focusing on the discovery of a new treatment to...